ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 103 filers reported holding ARATANA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,000 | -28.6% | 1,900 | -50.5% | 0.00% | – |
| Q1 2019 | $14,000 | -33.3% | 3,841 | +10.9% | 0.00% | – |
| Q4 2018 | $21,000 | -22.2% | 3,465 | -26.0% | 0.00% | – |
| Q3 2018 | $27,000 | +68.8% | 4,681 | +27.2% | 0.00% | – |
| Q2 2018 | $16,000 | -63.6% | 3,681 | -62.7% | 0.00% | – |
| Q1 2018 | $44,000 | +33.3% | 9,871 | +58.7% | 0.00% | – |
| Q4 2017 | $33,000 | +3.1% | 6,219 | +19.4% | 0.00% | – |
| Q3 2017 | $32,000 | -75.8% | 5,207 | -71.4% | 0.00% | -100.0% |
| Q2 2017 | $132,000 | -66.6% | 18,217 | -75.5% | 0.00% | -80.0% |
| Q1 2017 | $395,000 | +7800.0% | 74,486 | +12967.7% | 0.01% | – |
| Q3 2016 | $5,000 | +25.0% | 570 | -18.6% | 0.00% | – |
| Q1 2016 | $4,000 | 0.0% | 700 | +40.0% | 0.00% | – |
| Q3 2015 | $4,000 | -95.8% | 500 | -92.1% | 0.00% | -100.0% |
| Q2 2015 | $95,000 | -22.1% | 6,300 | -17.1% | 0.00% | -50.0% |
| Q1 2015 | $122,000 | +238.9% | 7,600 | +225.3% | 0.00% | +100.0% |
| Q2 2014 | $36,000 | – | 2,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $2,045,000 | 12.79% |
| Broadfin Capital, LLC | 3,085,979 | $28,885,000 | 2.59% |
| First Light Asset Management, LLC | 467,743 | $4,378,000 | 1.88% |
| AWM Investment Company, Inc. | 1,005,000 | $9,407,000 | 1.72% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $2,340,000 | 0.77% |
| Grandeur Peak Global Advisors, LLC | 394,450 | $3,692,000 | 0.72% |
| TURNER INVESTMENTS LLC | 208,660 | $1,953,000 | 0.65% |
| WALL STREET ASSOCIATES | 197,400 | $1,848,000 | 0.63% |
| TFS CAPITAL LLC | 192,848 | $1,805,000 | 0.43% |
| GENERAL AMERICAN INVESTORS CO INC | 412,101 | $3,857,000 | 0.39% |